2023
Mosa, A. I., Campo, D. S., Khudyakov, Y., AbouHaidar, M. G., Gehring, A. J., Zahoor, A., . . . Feld, J. J. (2023). Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 120(24). doi:10.1073/pnas.2220294120DOI: 10.1073/pnas.2220294120
2022
Chumbe, A., Urbanowicz, R. A., Sliepen, K., Koekkoek, S. M., Molenkamp, R., Tarr, A. W., . . . van Gils, M. J. (2022). Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus.. The Journal of general virology, 103(11). doi:10.1099/jgv.0.001801DOI: 10.1099/jgv.0.001801
Astbury, S., Reynolds, C. J., Butler, D. K., Muñoz‐Sandoval, D. C., Lin, K., Pieper, F. P., . . . Vijay, A. (n.d.). HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19. Immunology. doi:10.1111/imm.13450DOI: 10.1111/imm.13450
Martynova, E., Rizvanov, A., Urbanowicz, R. A., & Khaiboullina, S. (n.d.). Inflammasome Contribution to the Activation of Th1, Th2, and Th17 Immune Responses. Frontiers in Microbiology, 13. doi:10.3389/fmicb.2022.851835DOI: 10.3389/fmicb.2022.851835
2021
Martynova, E., Hamza, S., Garanina, E. E., Kabwe, E., Markelova, M., Shakirova, V., . . . Khaiboullina, S. F. (2021). Long Term Immune Response Produced by the SputnikV Vaccine. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(20). doi:10.3390/ijms222011211DOI: 10.3390/ijms222011211
Salas, J. H., Urbanowicz, R. A., Guest, J. D., Frumento, N., Figueroa, A., Clark, K. E., . . . Bailey, J. R. (2021). An antigenically diverse, representative panel of envelope glycoproteins for HCV vaccine development. Gastroenterology. doi:10.1053/j.gastro.2021.10.005DOI: 10.1053/j.gastro.2021.10.005
Ruiz-Jimenez, F., Perez-Olais, J. H., Raymond, C., King, B. J., McClure, C. P., Urbanowicz, R. A., & Ball, J. K. (2021). Challenges on the development of a pseudotyping assay for Zika glycoproteins. JOURNAL OF MEDICAL MICROBIOLOGY, 70(9). doi:10.1099/jmm.0.001413DOI: 10.1099/jmm.0.001413
Davidyuk, Y. N., Kabwe, E., Shamsutdinov, A. F., Knyazeva, A. V., Martynova, E. V., Ismagilova, R. K., . . . Morzunov, S. P. (2021). The Distribution of <i>Puumala orthohantavirus</i> Genome Variants Correlates with the Regional Landscapes in the Trans-Kama Area of the Republic of Tatarstan. PATHOGENS, 10(9). doi:10.3390/pathogens10091169DOI: 10.3390/pathogens10091169
Urbanowicz, R. A., Tsoleridis, T., Jackson, H. J., Cusin, L., Duncan, J. D., Chappell, J. G., . . . Ollivere, B. J. (2021). Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection. SCIENCE TRANSLATIONAL MEDICINE, 13(609). doi:10.1126/scitranslmed.abj0847DOI: 10.1126/scitranslmed.abj0847
Capone, S., Raggioli, A., Gentile, M., Battella, S., Lahm, A., Sommella, A., . . . Vitelli, A. (2021). Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19. MOLECULAR THERAPY, 29(8), 2412-2423. doi:10.1016/j.ymthe.2021.04.022DOI: 10.1016/j.ymthe.2021.04.022
Brentville, V. A., Vankemmelbeke, M., Metheringham, R. L., Symonds, P., Cook, K. W., Urbanowicz, R. A., . . . Durrant, L. G. (2021). SARS-CoV-2 spike RBD and nucleocapsid encoding DNA vaccine elicits T cell and neutralising antibody responses that cross react with variants. doi:10.1101/2021.06.18.448932DOI: 10.1101/2021.06.18.448932
Napolitano, F., Merone, R., Abbate, A., Ammendola, V., Horncastle, E., Lanzaro, F., . . . Vitelli, A. (2021). Correction: A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.. PLoS neglected tropical diseases, 15(4), e0009348. doi:10.1371/journal.pntd.0009348DOI: 10.1371/journal.pntd.0009348
2020
The Relationship of the Mechanisms of the Pathogenesis of Multiple Sclerosis and the Expression of Endogenous Retroviruses (Journal article)
Lezhnyova, V. R., Martynova, E. V., Khaiboullin, T. I., Urbanowicz, R. A., Khaiboullina, S. F., & Rizvanov, A. A. (2020). The Relationship of the Mechanisms of the Pathogenesis of Multiple Sclerosis and the Expression of Endogenous Retroviruses. BIOLOGY-BASEL, 9(12). doi:10.3390/biology9120464DOI: 10.3390/biology9120464
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity (Journal article)
Mueller, H., Fehling, S. K., Dorna, J., Urbanowicz, R. A., Oestereich, L., Krebs, Y., . . . Strecker, T. (2020). Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity. NPJ VACCINES, 5(1). doi:10.1038/s41541-020-00219-xDOI: 10.1038/s41541-020-00219-x
Polymer microarrays rapidly identify competitive adsorbents of virus-like particles (Journal article)
Blok, A. J., Gurnani, P., Xenopoulos, A., Burroughs, L., Duncan, J., Urbanowicz, R. A., . . . Alexander, M. R. (2020). Polymer microarrays rapidly identify competitive adsorbents of virus-like particles. BIOINTERPHASES, 15(6). doi:10.1116/6.0000586DOI: 10.1116/6.0000586
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization (Journal article)
Pierce, B. G., Keck, Z. -Y., Wang, R., Lau, P., Garagusi, K., Elkholy, K., . . . Foung, S. K. H. (2020). Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization. JOURNAL OF VIROLOGY, 94(22). doi:10.1128/JVI.00704-20DOI: 10.1128/JVI.00704-20
A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice. (Journal article)
Mosa, A. I., Urbanowicz, R. A., AbouHaidar, M. G., Tavis, J. E., Ball, J. K., & Feld, J. J. (2020). A bivalent HCV peptide vaccine elicits pan-genotypic neutralizing antibodies in mice.. Vaccine, 38(44), 6864-6867. doi:10.1016/j.vaccine.2020.08.066DOI: 10.1016/j.vaccine.2020.08.066
Orthohantaviruses, Emerging Zoonotic Pathogens (Journal article)
Kabwe, E., Davidyuk, Y., Shamsutdinov, A., Garanina, E., Martynova, E., Kitaeva, K., . . . Khaiboullina, S. (2020). Orthohantaviruses, Emerging Zoonotic Pathogens. PATHOGENS, 9(9). doi:10.3390/pathogens9090775DOI: 10.3390/pathogens9090775
Mosa, A. I., AbouHaidar, M. G., Urbanowicz, R. A., Tavis, J. E., Ball, J. K., & Feld, J. J. (2020). Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV.. Virology journal, 17(1), 140. doi:10.1186/s12985-020-01408-9DOI: 10.1186/s12985-020-01408-9
Tighe, P., Urbanowicz, R., Fairclough, L., McClure, P., Thomson, B., Gomez, N., . . . Tarr, A. (2020). Potent anti-SARS-CoV-2 Antibody Responses are Associated with Better Prognosis in Hospital Inpatient COVID-19 Disease. doi:10.1101/2020.08.22.20176834DOI: 10.1101/2020.08.22.20176834
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity. (Journal article)
Müller, H., Fehling, S. K., Dorna, J., Urbanowicz, R. A., Oestereich, L., Krebs, Y., . . . Strecker, T. (2020). Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.. NPJ vaccines, 5(1), 71. doi:10.1038/s41541-020-00219-xDOI: 10.1038/s41541-020-00219-x
Napolitano, F., Merone, R., Abbate, A., Ammendola, V., Horncastle, E., Lanzaro, F., . . . Vitelli, A. (2020). A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.. PLoS neglected tropical diseases, 14(7), e0008459. doi:10.1371/journal.pntd.0008459DOI: 10.1371/journal.pntd.0008459
Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization (Journal article)
Pierce, B., Keck, Z. -Y., Wang, R., Lau, P., Garagusi, K., Elkholy, K., . . . Foung, S. K. H. (2020). Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization. doi:10.1101/2020.04.15.044073DOI: 10.1101/2020.04.15.044073
Hepatitis C Virus Vaccine: Challenges and Prospects (Journal article)
Duncan, J. D., Urbanowicz, R. A., Tarr, A. W., & Ball, J. K. (2020). Hepatitis C Virus Vaccine: Challenges and Prospects. VACCINES, 8(1). doi:10.3390/vaccines8010090DOI: 10.3390/vaccines8010090
2019
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells (Journal article)
Urbanowicz, R. A., Wang, R., Schiel, J. E., Keck, Z. -Y., Kerzic, M. C., Lau, P., . . . Fuerst, T. R. (2019). Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells. JOURNAL OF VIROLOGY, 93(7). doi:10.1128/JVI.01403-18DOI: 10.1128/JVI.01403-18
Expression of human ficolin-2 in hepatocytes confers resistance to infection by diverse hepatotropic viruses (Journal article)
Jalal, P. J., Urbanowicz, R. A., Horncastle, E., Pathak, M., Goddard, C., Saeed, A., . . . Tarr, A. W. (2019). Expression of human ficolin-2 in hepatocytes confers resistance to infection by diverse hepatotropic viruses. JOURNAL OF MEDICAL MICROBIOLOGY, 68(4), 642-648. doi:10.1099/jmm.0.000935DOI: 10.1099/jmm.0.000935
Cloning and Analysis of Authentic Patient-Derived HCV E1/E2 Glycoproteins (Chapter)
Urbanowicz, R. A., Ball, J. K., & Tarr, A. W. (2019). Cloning and Analysis of Authentic Patient-Derived HCV E1/E2 Glycoproteins. In HEPATITIS C VIRUS PROTOCOLS (Vol. 1911, pp. 275-294). doi:10.1007/978-1-4939-8976-8_19DOI: 10.1007/978-1-4939-8976-8_19
InFusion Cloning for the Generation of Biologically Relevant HCV Chimeric Molecular Clones (Chapter)
King, B., Urbanowicz, R., Tarr, A. W., Ball, J. K., & McClure, C. P. (2019). InFusion Cloning for the Generation of Biologically Relevant HCV Chimeric Molecular Clones. In HEPATITIS C VIRUS PROTOCOLS (Vol. 1911, pp. 93-104). doi:10.1007/978-1-4939-8976-8_6DOI: 10.1007/978-1-4939-8976-8_6
Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp) (Chapter)
Bailey, J. R., Urbanowicz, R. A., Ball, J. K., Law, M., & Foung, S. K. H. (2019). Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp). In HEPATITIS C VIRUS PROTOCOLS (Vol. 1911, pp. 441-450). doi:10.1007/978-1-4939-8976-8_30DOI: 10.1007/978-1-4939-8976-8_30
2018
Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies (Journal article)
Tarr, A. W., Backx, M., Hamed, M. R., Urbanowicz, R. A., McClure, C. P., Brown, R. J. P., & Ball, J. K. (2018). Immunization with a synthetic consensus hepatitis C virus E2 glycoprotein ectodomain elicits virus-neutralizing antibodies. ANTIVIRAL RESEARCH, 160, 25-37. doi:10.1016/j.antiviral.2018.09.005DOI: 10.1016/j.antiviral.2018.09.005
Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy? (Journal article)
Abo-zeid, Y., Urbanowicz, R. A., Thomson, B. J., Irving, W. L., Tarr, A. W., & Garnett, M. C. (2018). Enhanced nanoparticle uptake into virus infected cells: Could nanoparticles be useful in antiviral therapy?. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 547(1-2), 572-581. doi:10.1016/j.ijpharm.2018.06.027DOI: 10.1016/j.ijpharm.2018.06.027
2017
A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection <i>in vitro</i> and <i>in vivo</i> (Journal article)
Desombere, I., Mesalam, A. A., Urbanowicz, R. A., Van Houtte, F., Verhoye, L., Keck, Z. -Y., . . . Meuleman, P. (2017). A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection <i>in vitro</i> and <i>in vivo</i>. ANTIVIRAL RESEARCH, 148, 53-64. doi:10.1016/j.antiviral.2017.10.015DOI: 10.1016/j.antiviral.2017.10.015
2016
Human Adaptation of Ebola Virus during the West African Outbreak (Journal article)
Urbanowicz, R. A., McClure, C. P., Sakuntabhai, A., Sall, A. A., Kobinger, G., Mueller, M. A., . . . Ball, J. K. (2016). Human Adaptation of Ebola Virus during the West African Outbreak. CELL, 167(4), 1079-+. doi:10.1016/j.cell.2016.10.013DOI: 10.1016/j.cell.2016.10.013
Flexible and rapid construction of viral chimeras applied to hepatitis C virus (Journal article)
McClure, C. P., Urbanowicz, R. A., King, B. J., Cano-Crespo, S., Tarr, A. W., & Ball, J. K. (2016). Flexible and rapid construction of viral chimeras applied to hepatitis C virus. JOURNAL OF GENERAL VIROLOGY, 97, 2187-2193. doi:10.1099/jgv.0.000530DOI: 10.1099/jgv.0.000530
Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay (Journal article)
Urbanowicz, R. A., McClure, C. P., King, B., Mason, C. P., Ball, J. K., & Tarr, A. W. (2016). Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay. JOURNAL OF GENERAL VIROLOGY, 97, 2265-2279. doi:10.1099/jgv.0.000537DOI: 10.1099/jgv.0.000537
Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals (Journal article)
Ferns, R. B., Tarr, A. W., Hue, S., Urbanowicz, R. A., McClure, C. P., Gilson, R., . . . Pillay, D. (2016). Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals. VIROLOGY, 492, 213-224. doi:10.1016/j.virol.2016.02.003DOI: 10.1016/j.virol.2016.02.003
Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb (Journal article)
Paciello, R., Urbanowicz, R. A., Riccio, G., Sasso, E., McClure, C. P., Zambrano, N., . . . De Lorenzo, C. (2016). Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb. JOURNAL OF GENERAL VIROLOGY, 97, 82-94. doi:10.1099/jgv.0.000330DOI: 10.1099/jgv.0.000330
2015
A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance (Journal article)
Urbanowicz, R. A., McClure, C. P., Brown, R. J. P., Tsoleridis, T., PerssoN, M. A. A., Krey, T., . . . Tarr, A. W. (2016). A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance. JOURNAL OF VIROLOGY, 90(7), 3288-3301. doi:10.1128/JVI.02700-15DOI: 10.1128/JVI.02700-15
An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule (Journal article)
Nigro, E., Colavita, I., Sarnataro, D., Scudiero, O., Zambrano, G., Granata, V., . . . Pessi, A. (2015). An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule. SCIENTIFIC REPORTS, 5. doi:10.1038/srep18450DOI: 10.1038/srep18450
Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin (Journal article)
Urbanowicz, R. A., Lacek, K., Lahm, A., Bienkowska-Szewczyk, K., Ball, J. K., Nicosia, A., . . . Pessi, A. (2015). Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin. JOURNAL OF PEPTIDE SCIENCE, 21(9), 743-749. doi:10.1002/psc.2802DOI: 10.1002/psc.2802
2014
Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation (Journal article)
Lacek, K., Urbanowicz, R. A., Troise, F., De Lorenzo, C., Severino, V., Di Maro, A., . . . Pessi, A. (2014). Dramatic Potentiation of the Antiviral Activity of HIV Antibodies by Cholesterol Conjugation. JOURNAL OF BIOLOGICAL CHEMISTRY, 289(50), 35015-35028. doi:10.1074/jbc.M114.591826DOI: 10.1074/jbc.M114.591826
Analysis of Serine Codon Conservation Reveals Diverse Phenotypic Constraints on Hepatitis C Virus Glycoprotein Evolution (Journal article)
Brown, R. J. P., Koutsoudakis, G., Urbanowicz, R. A., Mirza, D., Ginkel, C., Riebesehl, N., . . . Ball, J. K. (2014). Analysis of Serine Codon Conservation Reveals Diverse Phenotypic Constraints on Hepatitis C Virus Glycoprotein Evolution. JOURNAL OF VIROLOGY, 88(1), 667-678. doi:10.1128/JVI.01745-13DOI: 10.1128/JVI.01745-13
Recombinant Human L-Ficolin Directly Neutralizes Hepatitis C Virus Entry (Journal article)
Hamed, M. R., Brown, R. J. P., Zothner, C., Urbanowicz, R. A., Mason, C. P., Krarup, A., . . . Tarr, A. W. (2014). Recombinant Human L-Ficolin Directly Neutralizes Hepatitis C Virus Entry. JOURNAL OF INNATE IMMUNITY, 6(5), 676-684. doi:10.1159/000362209DOI: 10.1159/000362209
2013
An Alpaca Nanobody Inhibits Hepatitis C Virus Entry and Cell-to-Cell Transmission (Journal article)
Tarr, A. W., Lafaye, P., Meredith, L., Damier-Piolle, L., Urbanowicz, R. A., Meola, A., . . . Krey, T. (2013). An Alpaca Nanobody Inhibits Hepatitis C Virus Entry and Cell-to-Cell Transmission. HEPATOLOGY, 58(3), 932-939. doi:10.1002/hep.26430DOI: 10.1002/hep.26430
A NANOBODY RECOGNIZING A NOVEL EPITOPE IN HEPATITIS C VIRUS GLYCOPROTEIN E2 BROADLY NEUTRALIZES VIRUS ENTRY AND INHIBITS CELL-CELL TRANSMISSION (Conference Paper)
Tarr, A. W., Lafaye, P., Damier-Piolle, L., Meredith, L., Urbanowicz, R. A., Meola, A., . . . Krey, T. (2013). A NANOBODY RECOGNIZING A NOVEL EPITOPE IN HEPATITIS C VIRUS GLYCOPROTEIN E2 BROADLY NEUTRALIZES VIRUS ENTRY AND INHIBITS CELL-CELL TRANSMISSION. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S479). doi:10.1016/S0168-8278(13)61179-4DOI: 10.1016/S0168-8278(13)61179-4
Differential Activation of Killer Cells in the Circulation and the Lung: A Study of Current Smoking Status and Chronic Obstructive Pulmonary Disease (COPD) (Journal article)
Wang, J., Urbanowicz, R. A., Tighe, P. J., Todd, I., Corne, J. M., & Fairclough, L. C. (2013). Differential Activation of Killer Cells in the Circulation and the Lung: A Study of Current Smoking Status and Chronic Obstructive Pulmonary Disease (COPD). PLOS ONE, 8(3). doi:10.1371/journal.pone.0058556DOI: 10.1371/journal.pone.0058556
2012
Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization (Journal article)
Tarr, A. W., Urbanowicz, R. A., Jayaraj, D., Brown, R. J. P., McKeating, J. A., Irving, W. L., & Ball, J. K. (2012). Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization. JOURNAL OF VIROLOGY, 86(5), 2739-2749. doi:10.1128/JVI.06492-11DOI: 10.1128/JVI.06492-11
The Role of Humoral Innate Immunity in Hepatitis C Virus Infection (Journal article)
Tarr, A. W., Urbanowicz, R. A., & Ball, J. K. (2012). The Role of Humoral Innate Immunity in Hepatitis C Virus Infection. VIRUSES-BASEL, 4(1), 1-27. doi:10.3390/v4010001DOI: 10.3390/v4010001
The role of neutralizing antibodies in hepatitis C virus infection (Journal article)
Edwards, V. C., Tarr, A. W., Urbanowicz, R. A., & Ball, J. K. (2012). The role of neutralizing antibodies in hepatitis C virus infection. JOURNAL OF GENERAL VIROLOGY, 93, 1-19. doi:10.1099/vir.0.035956-0DOI: 10.1099/vir.0.035956-0
2011
Hepatitis C Patient-Derived Glycoproteins Exhibit Marked Differences in Susceptibility to Serum Neutralizing Antibodies: Genetic Subtype Defines Antigenic but Not Neutralization Serotype (Journal article)
Tarr, A. W., Urbanowicz, R. A., Hamed, M. R., Albecka, A., McClure, C. P., Brown, R. J. P., . . . Ball, J. K. (2011). Hepatitis C Patient-Derived Glycoproteins Exhibit Marked Differences in Susceptibility to Serum Neutralizing Antibodies: Genetic Subtype Defines Antigenic but Not Neutralization Serotype. JOURNAL OF VIROLOGY, 85(9), 4246-4257. doi:10.1128/JVI.01332-10DOI: 10.1128/JVI.01332-10
2010
Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients (Journal article)
Urbanowicz, R. A., Lamb, J. R., Todd, I., Corne, J. M., & Fairclough, L. C. (2010). Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients. RESPIRATORY RESEARCH, 11. doi:10.1186/1465-9921-11-76DOI: 10.1186/1465-9921-11-76
Quantitative Validation and Comparison of Multiplex Cytokine Kits (Journal article)
Richens, J. L., Urbanowicz, R. A., Metcalf, R., Corne, J., O'Shea, P., & Fairclough, L. (2010). Quantitative Validation and Comparison of Multiplex Cytokine Kits. JOURNAL OF BIOMOLECULAR SCREENING, 15(5), 562-568. doi:10.1177/1087057110362099DOI: 10.1177/1087057110362099
2009
Altered effector function of peripheral cytotoxic cells in COPD (Journal article)
Urbanowicz, R. A., Lamb, J. R., Todd, I., Corne, J. M., & Fairclough, L. C. (2009). Altered effector function of peripheral cytotoxic cells in COPD. RESPIRATORY RESEARCH, 10. doi:10.1186/1465-9921-10-53DOI: 10.1186/1465-9921-10-53
Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease (Journal article)
Richens, J. L., Urbanowicz, R. A., Lunt, E. A. M., Metcalf, R., Corne, J., Fairclough, L., & O'Shea, P. (2009). Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease. RESPIRATORY RESEARCH, 10. doi:10.1186/1465-9921-10-29DOI: 10.1186/1465-9921-10-29
Cytotoxic Cells in Bronchoalveolar Lavage (BAL) Fluid from COPD Patients (Conference Paper)
Wang, J., Urbanowicz, R. A., Corne, J. M., Todd, I., & Fairclough, L. C. (2009). Cytotoxic Cells in Bronchoalveolar Lavage (BAL) Fluid from COPD Patients. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 179. Retrieved from https://www.webofscience.com/
Cytotoxic Cells in the Induced Sputum of Smokers with COPD (Conference Paper)
Urbanowicz, R. A., Lamb, J. R., Corne, J. M., & Fairclough, L. C. (2009). Cytotoxic Cells in the Induced Sputum of Smokers with COPD. In AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Vol. 179. Retrieved from https://www.webofscience.com/
2008
Killer cells in chronic obstructive pulmonary disease (Journal article)
Fairclough, L., Urbanowicz, R. A., Corne, J., & Lamb, J. R. (2008). Killer cells in chronic obstructive pulmonary disease. CLINICAL SCIENCE, 114(7-8), 533-541. doi:10.1042/CS20070356DOI: 10.1042/CS20070356
2004
Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance (Journal article)
McGinnity, D. F., Soars, M. G., Urbanowicz, R. A., & Riley, R. J. (2004). Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. DRUG METABOLISM AND DISPOSITION, 32(11), 1247-1253. doi:10.1124/dmd.104.000026DOI: 10.1124/dmd.104.000026
Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance (Conference Paper)
McGinnity, D. F., Soars, M. G., Urbanowicz, R., & Riley, R. J. (2004). Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance. In DRUG METABOLISM REVIEWS Vol. 36 (pp. 106). Retrieved from https://www.webofscience.com/
